The 340B Program was designed to stretch the limited federal resources given to non-profit healthcare providers WITHOUT RAISING TAXES.
These healthcare providers, like Prism Health North Texas, use the savings from the 340B Program to provide affordable healthcare to Texans, including HIV/STI testing, PrEP, primary and preventative care, and more.
The 340B Drug Discount Program requires drug companies to provide drugs at a discounted price to certain types of non-profit hospitals and clinics that, in turn, use their 340B savings to underwrite the cost of serving patients in their communities. Without 340B, the cost of providing this affordable public healthcare would fall on you, the taxpayer.
Unfortunately, over thirty drug companies are currently unlawfully restricting healthcare providers’ access to the 340B discount, redirecting the savings into Big Pharma’s pockets.
What is 340B?
First established in 1992 through bipartisan legislation, the federal 340B drug discount program operates on the simple principle of requiring drug companies to provide drugs at a discounted price to certain types of non-profit hospitals and clinics that, in turn, use their 340B savings to provide affordable healthcare in their communities. That reinvestment in patients and communities without taxpayer dollars has made the 340B program successful. 340B providers can benefit their communities more with their limited dollars.
For over 30 years, the 340B program has consistently helped safety net providers meet their communities’ unique public health needs. Congress has acted several times to extend program eligibility to additional categories of hospitals. However, despite affecting just two percent of all drug sales in the United States, the program remains deeply unpopular within the drug industry.
Defending the 340B Program
Without a significant and sustained effort to raise public awareness of the 340B program’s benefits, the program faces an uncertain future. Providers and their healthcare industry supporters have worked to defend the 340B program, recognizing its actual value in providing patients with affordable care, but they need YOUR help.
ACT NOW to defend the 340B program against ongoing attacks by the drug industry.
Texans, join our community!
Get monthly updates about how to #Defend340B and take action in your community.
"*" indicates required fields
Ready to act now? Send a message to your policymaker today asking them to #Defend340B.
Don’t let Big Pharma shrink the program, helping LGBTQ+ community members access affordable, affirming healthcare.
Background on 340B Drug Pricing Program
Section 340B of the Public Health Service Act
The federal 340B Drug Discount Program is a lifeline that allows safety net providers to obtain prescription drugs at below-retail prices. The program was established with bipartisan support as part of the Veterans Health Care Act of 1992.
Health Resources & Services Administration (HRSA)
Office of Pharmacy Affairs, located within the Health Resources and Services Administration of the Department of Health and Human Services, administers the 340B program. HRSA and OPA are located in Rockville, MD, and are responsible for interpreting and implementing the 340B law.
OPA Information System (OPAIS)
Find 340B covered entities near you. Search the Office of Pharmacy Affairs Database to find Disproportionate Share Hospitals; Federally Qualified Health Centers; Rural Referral Centers; Sole Community Hospitals; Community Health Centers; Hemophilia Treatment Facilities; and Ryan White Clinics that rely on the 340B program.
Myth vs. Fact – 340B Coaltion
There’s a lot of misinformation about the 340B program out there. Get the facts about the intent of the program, who benefits from the 340B program, and why the 340B program is necessary to communities across the country.
Key Acronyms and Terms Related to the 340B Program
340B Health has listed several key acronyms and terms related to the 340B program. This includes government agencies, types of covered entities, legislation, nonprofit organizations, vendors, and more.